You are viewing: Rest Of Asia Pacific IV Equipment Market analysis
Part of: IV Equipment Market (Global)

The Rest Of Asia Pacific IV Equipment Market was valued at $35.67 Million in 2026 and projected to reach to $46.9 Million by 2031, representing a compound annual growth rate of 5.6%. Rest Of Asia Pacific's IV Equipment Market is poised for steady growth through 2031, driven by expanding healthcare infrastructure and increasing investments in medical technology across emerging economies.

Rest Of Asia Pacific IV Equipment Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Asia Pacific IV Equipment Market Trends and Insights

  • The region's IV equipment market is experiencing steady expansion driven by increasing healthcare infrastructure investments and rising demand for advanced infusion therapies across emerging economies.
  • Rest Of Asia Pacific's growth trajectory reflects improving access to medical devices and growing patient populations requiring intravenous treatment solutions. The Rest Of Asia Pacific IV Equipment Market is characterized by a 5.6% compound annual growth rate, indicating moderate but consistent market development through the forecast period.
  • Rest Of Asia Pacific benefits from expanding hospital networks, rising healthcare expenditure, and growing awareness of standardized IV delivery systems.
  • Rest Of Asia Pacific's market dynamics are shaped by both established healthcare providers and emerging medical device manufacturers seeking to capture growing demand in underserved regions..

Key Market Statistics

  • CAGR (2026-2031) 5.6% CAGR
  • Market Size, 2026 ~USD 35.67 Million
  • Forecast, 2031 ~USD 46.9 Million
  • Country Rest Of Asia Pacific

Rest Of Asia Pacific IV Equipment Market Overview

Market Valuation Growth :

Rest Of Asia Pacific IV Equipment Market is valued at $35.67 million in 2026, with projections reaching $46.90 million by 2031, representing a robust 5.6% CAGR over the forecast period.

Healthcare Infrastructure Expansion :

Emerging economies across Rest Of Asia Pacific are significantly investing in healthcare infrastructure, creating substantial demand for modern IV equipment and infusion therapy solutions.

Rising Infusion Therapy Adoption :

Increasing prevalence of chronic diseases and growing awareness of advanced infusion therapies are driving adoption of IV equipment across hospitals, clinics, and ambulatory care centers in the region.

Regional Growth Momentum :

Rest Of Asia Pacific demonstrates steady market expansion with a 5.6% CAGR, slightly below the global average of 6.1%, indicating emerging market potential with room for accelerated growth.

Rest Of Asia Pacific IV Equipment Market Dynamics

  • The region's growing middle-class population and rising healthcare expenditure are creating favorable conditions for IV equipment adoption in both urban and developing healthcare facilities. Key growth drivers include the rising incidence of chronic diseases, improved access to healthcare services, and government initiatives to modernize medical infrastructure.
  • As healthcare providers in Rest Of Asia Pacific seek to enhance patient care quality and operational efficiency, demand for advanced infusion systems and IV equipment will continue to accelerate, supporting the projected market expansion to $46.90 million by 2031..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Rest Of Asia Pacific IV Equipment Market is valued at $35.67 million in 2026 and will reach $46.90 million by 2031, representing a 5.6% CAGR.
    • Rest Of Asia Pacific's market growth is driven by expanding healthcare infrastructure and increasing adoption of advanced infusion technologies across emerging economies.
    • Rest Of Asia Pacific demonstrates steady demand for IV equipment supported by rising patient populations and improved hospital network development.
    • Rest Of Asia Pacific presents opportunities for both multinational and regional manufacturers to expand market presence in underserved healthcare segments.

    IV Equipment Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment NEEDLE-FREE CONNECTORS & EXTENSION SETS (Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 6.1% from 2026 to 2031
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 17.79 (2026)
    Revenue Forecast (Billions) ~USD 23.92 (2031)
    Segments Covered Type, Application, End User

    Rest Of Asia Pacific IV Equipment Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Type

    • Analgesia/Pain Management
    • Antibiotic/Antimicrobial Iv Therapy
    • Critical Care & Vasoactive Drug Infusion
    • Critical Care Nutrition
    • Gastrointestinal Disorders
    • Immunotherapy
    • Infusion Pumps
    • Iv Administration Sets & Tubing
    • Iv Catheters
    • Iv Drip Chambers
    • Needle-Free Connectors & Extension Sets
    • Neonatal & Pediatric Parenteral Nutrition
    • Oncology (Iv Chemotherapy)
    • Other Blood & Blood Products Transfusion Applications
    • Other Iv Equipment
    • Other Parenteral Nutrition Applications
    • Plasma Transfusion
    • Platelet Transfusion
    • Red Blood Cell Transfusion
    • Securement & Stabilization Devices
    • Sedation & Anesthesia Infusion

    By Application

    • Blood & Blood Products Transfusion
    • Diagnostic Testing
    • Fluid & Electrolyte Replacement
    • Medication Administration
    • Other Applications
    • Parenteral Nutrition (Pn)

    By End User

    • Ambulatory Surgical Centers
    • Ambulatory Surgical Centers (Ascs)
    • Home Care Settings
    • Hospitals
    • Other End Users
    • Outpatient Infusion & Specialty Clinics

    Target Audience

    • Medical Device Manufacturers : IV equipment manufacturers need Rest Of Asia Pacific-specific market data to identify growth opportunities, assess competitive positioning, and develop region-tailored product strategies.
    • Healthcare Investors & PE Firms : Investment professionals require detailed market valuations, CAGR projections, and growth drivers for Rest Of Asia Pacific to evaluate portfolio opportunities and funding decisions.
    • Hospital & Healthcare Facility Operators : Healthcare administrators need market insights on IV equipment trends and procurement patterns in Rest Of Asia Pacific to optimize equipment selection and budget planning.
    • Distributors & Supply Chain Partners : Regional distributors and logistics providers require market forecasts and demand projections for Rest Of Asia Pacific to optimize inventory management and distribution networks.
    • Healthcare Consultants & Analysts : Consulting firms and research analysts need comprehensive Rest Of Asia Pacific market data to support client advisory services, market assessments, and strategic recommendations.

    Key Companies in the Rest Of Asia Pacific IV Equipment Market

    CompanyHQOwnershipStrongest segments
    KINDRED HEALTHCARE INC.United StatesPrivate CompanyLong-term acute care hospital drug utilization,Inpatient rehabilitation facility drug utilization,Contract rehabilitation and ancillary services,
    ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyTurnkey automated manufacturing and assembly systems,Pre- and post-automation services,Contract manufacturing and value engineering,
    CONVATECUnited KingdomPublic CompanyAdvanced wound care,Ostomy care,Continence and critical care,
    IRADIMED CORPORATIONUnited StatesPublic CompanyMRidium 3870/3860+ MRI-compatible infusion pump systems and disposables,3880 MRI-compatible patient vital signs monitoring system and accessories,3600 FMD1 ferromagnetic detection devices and remote alarm units,
    POLY MEDICURE LTD.IndiaPublic CompanyInfusion & Transfusion Therapy,Critical Care & Anesthesia/Respiratory,Dialysis & Renal Care,
    CONMED CORPORATIONUnited StatesPublic CompanySports medicine & soft tissue fixation (BioBrace, Y-Knot, TruShot, Agro Knotless),Powered large & small bone systems (Hall brand),General surgery – insufflation & smoke management (AirSeal, Buffalo Filter),
    MALLINCKRODT PLCIrelandPrivate CompanyAutoimmune and rare disease therapies,Neurology and rheumatology specialty products,Neonatal respiratory and critical care therapies,
    BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyMedical Essentials (syringes, needles, catheters, sharps, specimen collection),Connected Care (infusion, medication management, automation, informatics),BioPharma Systems (prefillable drug delivery, CSTD, hazardous drug detection),
    BAXTERUnited StatesPublic CompanyMedical Products & Therapies (IV solutions, infusion systems, parenteral nutrition, dialysis-related therapies),Healthcare Systems & Technologies (smart beds, OR integration, monitoring, respiratory devices),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services),
    FRESENIUS SE & CO. KGAAGermanyPublic CompanyFresenius Helios (hospitals and outpatient care),IV generics and IV fluids,Clinical nutrition (enteral and parenteral),
    ICU MEDICAL, INC.United StatesPublic CompanyInfusion pumps and hardware,Infusion consumables and vascular access (Clave, Neutron, Tego, disinfection caps),IV solutions and diluents,
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    MOOG, INC.United StatesPublic CompanyMilitary Aircraft,Commercial Aircraft,Space and Defense,
    TELEFLEX INCORPORATEDUnited StatesPublic CompanyVascular access & emergency medicine (Arrow, EZ-IO, QuikClot, FAST1),Interventional cardiology & peripheral (GuideLiner, Turnpike, MANTA, DCBs, stents),Surgical products (Weck clips, MiniLap, staplers, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS),
    SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.ChinaPublic CompanyPatient monitoring, anesthesia, ventilators, and life-support,Ultrasound and medical imaging (radiology, emergency, critical care),In-vitro diagnostics (CLIA, chemistry, hematology),
    CARDINAL HEALTHUnited StatesPublic CompanyPharmaceutical Distribution (Branded & Generic),Specialty Pharmaceutical & Manufacturer Services,Medical Products & Cardinal-Branded Devices,
    AVANOS MEDICAL, INC.United StatesPublic CompanyDigestive health (Mic-Key, Corpak, NeoMed),Non-opioid surgical pain and recovery (ON-Q, ambIT, Game Ready),Interventional pain (COOLIEF, Trident, Esentec RFA),
    NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products,Pharmaceuticals (generic and kit products),
    JMS CO., LTD.United StatesPublic CompanyU.S. Retail Coffee,U.S. Retail Pet Foods and Snacks,U.S. Retail Frozen Handheld and Spreads,

    KINDRED HEALTHCARE INC.

    Kindred Healthcare Inc. is a private United States-based healthcare company founded in 1985 with 64,200 employees. The company operates healthcare facilities and provides related medical services.

    ATS AUTOMATION TOOLING SYSTEMS INC

    ATS Automation Tooling Systems Inc. is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.

    CONVATEC

    ConvaTec is a United Kingdom-based public company founded in 1978. The company manufactures and distributes medical devices and healthcare products globally.

    IRADIMED CORPORATION

    IraMed Corporation is a United States-based public company founded in 1992 with 166 employees. The company specializes in medical imaging and monitoring equipment.

    POLY MEDICURE LTD.

    Poly Medicure Ltd. is an Indian public company founded in 1995 with 3,082 employees. The company manufactures medical devices and healthcare products.

    CONMED CORPORATION

    ConMed Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company manufactures and distributes surgical and medical devices.

    MALLINCKRODT PLC

    Mallinckrodt PLC is an Ireland-based private company with a history dating to 1867 and 2,687 employees. The company operates in the pharmaceutical and medical device sectors.

    BECTON, DICKINSON AND COMPANY

    Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees. The company is a global leader in medical technology, manufacturing diagnostic and healthcare devices.

    BAXTER

    Baxter is a United States-based public company founded in 1931 with 37,500 employees. The company develops and manufactures medical devices, pharmaceuticals, and healthcare solutions.

    FRESENIUS SE & CO. KGAA

    Fresenius SE & Co. KGaA is a German public company founded in 1912 with 177,783 employees. The company is a global healthcare company providing dialysis, infusion therapy, and hospital products.

    ICU MEDICAL, INC.

    ICU Medical, Inc. is a United States-based public company founded in 1984 with 13,000 employees. The company manufactures critical care medical devices and infusion therapy products.

    TERUMO CORPORATION

    Terumo Corporation is a Japanese public company founded in 1921 with 30,591 employees. The company manufactures and distributes medical devices and healthcare products globally.

    MOOG, INC.

    Moog, Inc. is a United States-based public company founded in 1951 with 13,500 employees. The company manufactures precision motion and control products for aerospace, defense, and medical applications.

    TELEFLEX INCORPORATED

    Teleflex Incorporated is a United States-based public company founded in 1943 with 15,500 employees. The company designs and manufactures medical devices for critical care and surgical applications.

    SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

    Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a Chinese public company founded in 1991 with 21,288 employees. The company manufactures medical devices and diagnostic equipment.

    CARDINAL HEALTH

    Cardinal Health is a United States-based public company founded in 1979 with 55,392 employees. The company is a global healthcare services and products company serving hospitals and healthcare providers.

    AVANOS MEDICAL, INC.

    Avanos Medical, Inc. is a United States-based public company founded in 2014 with 2,287 employees. The company manufactures and distributes medical devices for healthcare applications.

    NIPRO

    Nipro is a Japanese public company founded in 1947 with 38,593 employees. The company manufactures medical devices, pharmaceuticals, and healthcare products.

    JMS CO., LTD.

    JMS Co., Ltd. is a United States-based public company founded in 1897 with 8,000 employees. The company manufactures medical devices and healthcare products.

    Reasons to Buy this Report

    • Emerging Market Opportunity Assessment : Gain detailed insights into Rest Of Asia Pacific's IV equipment market dynamics, identifying high-potential emerging economies and untapped market segments for strategic expansion.
    • Competitive Positioning Strategy : Understand regional market trends, growth drivers, and competitive landscape specific to Rest Of Asia Pacific to develop targeted market entry and positioning strategies.
    • Investment Decision Support : Access comprehensive market valuation data, CAGR projections, and growth forecasts for Rest Of Asia Pacific to support capital allocation and investment decisions.
    • Healthcare Infrastructure Insights : Analyze healthcare infrastructure expansion trends and modernization initiatives across Rest Of Asia Pacific to identify procurement opportunities and partnership potential.
    • Demand Forecasting Accuracy : Leverage region-specific market data and projections through 2031 to improve demand forecasting, supply chain planning, and resource allocation for Rest Of Asia Pacific operations.

    Frequently asked questions

    What is the current market size of IV Equipment in Rest Of Asia Pacific?

    Rest Of Asia Pacific's IV Equipment Market is estimated at $35.67 million in 2026 and is projected to grow to $46.90 million by 2031.

    What is the expected growth rate for Rest Of Asia Pacific's IV Equipment Market?

    Rest Of Asia Pacific's IV Equipment Market is expected to grow at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2031.

    What factors are driving growth in Rest Of Asia Pacific's IV Equipment Market?

    Rest Of Asia Pacific's market growth is driven by expanding healthcare infrastructure, rising healthcare expenditure, increasing patient populations, and growing adoption of standardized IV delivery systems.

    How does Rest Of Asia Pacific's IV Equipment Market compare to other regions?

    Rest Of Asia Pacific's 5.6% CAGR reflects moderate but consistent growth, positioning the region as a developing market with significant expansion potential compared to mature markets.

    What opportunities exist for manufacturers in Rest Of Asia Pacific's IV Equipment Market?

    Rest Of Asia Pacific offers opportunities for both multinational and regional manufacturers to capture growing demand through hospital network expansion, emerging economy development, and underserved healthcare segment penetration.

    RESEARCH METHODOLOGY

    This study relied heavily on both primary and secondary sources. The research process involved studying various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and key player strategies.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and company SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the IV equipment market. It was also used to obtain important information on key players, market classification & segmentation aligned with industry trends, and key developments from market and technology perspectives, down to the bottom-most level. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from leading companies and organizations in the IV equipment market. The primary demand-side sources include medical OEMs, medical device ISOs, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players, and gather insights into key industry trends & key market dynamics.

    Breakdown of Primary Interviews:

    A breakdown of the primary respondents for the IV equipment market (supply side) is provided below:

    IV Equipment Market 
 Size, and Share

    Note 1: Others include sales, marketing, and product managers.

    Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 2 billion,

    Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = USD 50 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    In this report, the global IV equipment market size was determined using the revenue share analysis of leading players. For this purpose, key market players were identified, and their revenues from the IV equipment business were determined using insights gathered during the primary and secondary research phases. Secondary research included analyzing the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, including CEOs, directors, and senior marketing executives.

    To calculate the global market value, segmental revenues were derived from the revenue mapping of major solution/service providers. This process involved the following steps:

    • Generating a list of major global players operating in the IV equipment market
    • Mapping annual revenues generated by major global players from the IV equipment segment (or nearest reported business unit/service category)
    • Revenue mapping of key players to cover a major share of the global market as of 2024
    • Extrapolating the global value of the IV equipment industry

    Global IV Equipment Market Size: Top-down & Bottom-up Approach

    IV Equipment Market : Top-Down and Bottom-Up Approach

    IV Equipment Market  Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the overall market size through the market size estimation process explained above, the global IV equipment market was segmented and subsegmented. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and obtain exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the IV equipment market was validated using both top-down and bottom-up approaches.

    Market Definition

    IV equipment refers to the complete set of medical devices, accessories, and consumables used to deliver fluids, medications, nutrients, and blood products directly into a patient’s bloodstream through intravenous (IV) access. It includes infusion pumps, IV administration sets, catheters and cannulas, needle-free connectors, extension sets, securement devices, and related safety components designed to ensure accurate, controlled, and sterile delivery of therapies in hospitals, outpatient centers, and home care settings. IV equipment is essential for hydration, drug infusion, chemotherapy, parenteral nutrition, anesthesia, critical care, and emergency treatment.

    Key Stakeholders

    • Manufacturers of IV equipment
    • Distributors of IV equipment
    • Hospitals, clinics, and infusion centers
    • Ambulatory surgery centers
    • Non-government organizations
    • Government regulatory authorities
    • Contract manufacturers & third-party suppliers
    • Research laboratories & academic institutes
    • Clinical research organizations (CROs)
    • Government & non-governmental regulatory authorities
    • Market research & consulting firms

    Report Objectives

    • To define, describe, and forecast the IV equipment market based on type, application, end user, and region
    • To provide detailed information regarding the major factors influencing the growth potential of the global IV equipment market (drivers, restraints, opportunities, challenges, and trends)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global IV equipment market
    • To analyze key growth opportunities in the global IV equipment market for key stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the global IV equipment market in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the global IV equipment market and comprehensively analyze their market shares and core competencies
    • To track and analyze the competitive developments undertaken in the global IV equipment market, such as agreements, collaborations, partnerships, expansions, and acquisitions

    Customization Options

    Based on the market data provided, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the present global IV equipment market report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of the top twelve companies

    Company Information

    • Detailed analysis and profiling of additional market players (up to 10)

    Geographic Analysis

    • Further breakdown of the Rest of Europe IV equipment market into Russia, Finland, Switzerland, Turkey, the Czech Republic, the Netherlands, Norway, Poland, Portugal, Romania, Estonia, Austria, and Belgium
    • Further breakdown of the Rest of Asia Pacific IV equipment market into Taiwan, New Zealand, and Sri Lanka
    • Further breakdown of the Rest of Latin America IV equipment market into Uruguay, Costa Rica, Bolivia, Venezuela, and Paraguay

    Get the Full IV Equipment Market Report

    Full forecast, segment splits, and company analysis for all IV Equipment Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status